US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist

3.960
+0.100+2.59%

Close Jul 26 16:00 ET

21.50MMarket Cap-1207P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-32.12%-3.94M

51.31%-12.18M

6.99%-3.74M

65.99%-2.24M

63.87%-3.22M

45.79%-2.98M

33.63%-25.01M

60.50%-4.02M

19.93%-6.59M

-14.84%-8.9M

Net income from continuing operations

35.84%-2.81M

87.32%-14.29M

-40.99%-3.44M

20.38%-3.2M

96.68%-3.26M

44.81%-4.38M

-203.45%-112.66M

68.51%-2.44M

57.42%-4.02M

-858.52%-98.26M

Operating gains losses

-507.16%-56.18K

113.83%38.93K

133.99%78.61K

111.83%2.88K

63.53%-56.36K

110.13%13.8K

11.30%-281.53K

147.88%33.6K

-211.17%-24.35K

-161.13%-154.57K

Depreciation and amortization

1,401.71%6.16K

-96.22%7.05K

309.06%4.99K

-97.67%1.43K

-99.65%224

-99.36%410

-31.37%186.45K

-103.61%-2.39K

-11.63%61.37K

5.74%63.69K

Other non cash items

----

--72.52M

--0

----

Change In working capital

-184.77%-1.16M

192.05%1.62M

72.23%-462.86K

133.38%882.21K

-108.06%-170.99K

218.87%1.37M

78.88%-1.76M

63.04%-1.67M

-190.78%-2.64M

557.82%2.12M

-Change in prepaid assets

-37.91%213.64K

-79.36%451.99K

35.98%-625.14K

-35.85%666.89K

-93.46%66.19K

-69.15%344.06K

2,103.04%2.19M

64.59%-976.42K

39.83%1.04M

3.97%1.01M

-Change in payables and accrued expense

-196.92%-994.68K

116.95%637.74K

46.59%-366.69K

105.97%215.32K

-120.49%-237.18K

264.10%1.03M

52.67%-3.76M

59.37%-686.5K

-127.89%-3.61M

296.06%1.16M

-Change in other current liabilities

----

--0

----

30.52%-186.7K

93.66%-4.01K

-8.47%-75.38K

21.44%-47.2K

-Change in other working capital

---380.57K

--528.97K

----

Cash from discontinued investing activities

Operating cash flow

-32.12%-3.94M

51.31%-12.18M

6.99%-3.74M

65.99%-2.24M

63.87%-3.22M

45.79%-2.98M

33.63%-25.01M

60.50%-4.02M

19.93%-6.59M

-14.84%-8.9M

Investing cash flow

Cash flow from continuing investing activities

-7.98K

-93.09K

-7.15K

Net PPE purchase and sale

---7.98K

---93.09K

---7.15K

----

--0

----

Cash from discontinued investing activities

Investing cash flow

---7.98K

---93.09K

---7.15K

----

--0

----

Financing cash flow

Cash flow from continuing financing activities

186.18%14.71M

652.59%5.14M

5.14M

-60.91%682.97K

-94.06%98.53K

572.01%584.45K

Net common stock issuance

176.38%16M

747.61%5.79M

--0

--5.79M

-55.61%682.97K

-93.60%98.53K

--584.45K

--0

Proceeds from stock option exercised by employees

----

--0

----

--0

----

Net other financing activities

-98.77%-1.29M

---648.93K

--0

---648.93K

----

Cash from discontinued financing activities

Financing cash flow

186.18%14.71M

652.59%5.14M

--0

--5.14M

-60.91%682.97K

-94.06%98.53K

572.01%584.45K

--0

Net cash flow

Beginning cash position

-24.80%21.65M

-45.76%28.79M

-23.31%25.39M

-29.02%27.73M

-34.95%31M

-45.76%28.79M

-40.38%53.08M

-46.10%33.11M

-44.04%39.06M

-38.61%47.65M

Current changes in cash

398.21%10.77M

70.69%-7.13M

4.47%-3.75M

61.25%-2.33M

63.87%-3.22M

139.32%2.16M

32.31%-24.33M

53.96%-3.92M

26.25%-6.01M

-14.84%-8.9M

Effect of exchange rate changes

-105.01%-2.41K

-121.67%-8.4K

100.09%383

-105.89%-3.44K

-117.08%-53.5K

-32.22%48.16K

1,671.06%38.76K

-342.78%-403.97K

125.51%58.42K

619.10%313.25K

End cash Position

4.57%32.41M

-24.80%21.65M

-23.31%25.39M

-29.02%27.73M

-34.95%31M

-45.76%28.79M

-46.10%33.11M

-44.04%39.06M

Free cash flow

-32.39%-3.94M

50.94%-12.27M

6.81%-3.75M

64.69%-2.33M

63.87%-3.22M

45.79%-2.98M

33.63%-25.01M

60.50%-4.02M

19.93%-6.59M

-14.84%-8.9M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-32.12%-3.94M	51.31%-12.18M	6.99%-3.74M	65.99%-2.24M	63.87%-3.22M	45.79%-2.98M	33.63%-25.01M	60.50%-4.02M	19.93%-6.59M	-14.84%-8.9M
Net income from continuing operations	35.84%-2.81M	87.32%-14.29M	-40.99%-3.44M	20.38%-3.2M	96.68%-3.26M	44.81%-4.38M	-203.45%-112.66M	68.51%-2.44M	57.42%-4.02M	-858.52%-98.26M
Operating gains losses	-507.16%-56.18K	113.83%38.93K	133.99%78.61K	111.83%2.88K	63.53%-56.36K	110.13%13.8K	11.30%-281.53K	147.88%33.6K	-211.17%-24.35K	-161.13%-154.57K
Depreciation and amortization	1,401.71%6.16K	-96.22%7.05K	309.06%4.99K	-97.67%1.43K	-99.65%224	-99.36%410	-31.37%186.45K	-103.61%-2.39K	-11.63%61.37K	5.74%63.69K
Other non cash items	----	----	----	----	----	----	--72.52M	--0	--0	----
Change In working capital	-184.77%-1.16M	192.05%1.62M	72.23%-462.86K	133.38%882.21K	-108.06%-170.99K	218.87%1.37M	78.88%-1.76M	63.04%-1.67M	-190.78%-2.64M	557.82%2.12M
-Change in prepaid assets	-37.91%213.64K	-79.36%451.99K	35.98%-625.14K	-35.85%666.89K	-93.46%66.19K	-69.15%344.06K	2,103.04%2.19M	64.59%-976.42K	39.83%1.04M	3.97%1.01M
-Change in payables and accrued expense	-196.92%-994.68K	116.95%637.74K	46.59%-366.69K	105.97%215.32K	-120.49%-237.18K	264.10%1.03M	52.67%-3.76M	59.37%-686.5K	-127.89%-3.61M	296.06%1.16M
-Change in other current liabilities	----	--0	--0	--0	----	----	30.52%-186.7K	93.66%-4.01K	-8.47%-75.38K	21.44%-47.2K
-Change in other working capital	---380.57K	--528.97K	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-32.12%-3.94M	51.31%-12.18M	6.99%-3.74M	65.99%-2.24M	63.87%-3.22M	45.79%-2.98M	33.63%-25.01M	60.50%-4.02M	19.93%-6.59M	-14.84%-8.9M
Investing cash flow
Cash flow from continuing investing activities	-7.98K	-93.09K	-7.15K			0	0	0
Net PPE purchase and sale	---7.98K	---93.09K	---7.15K	----	----	--0	--0	--0	----	----
Cash from discontinued investing activities
Investing cash flow	---7.98K	---93.09K	---7.15K	----	----	--0	--0	--0	----	----
Financing cash flow
Cash flow from continuing financing activities	186.18%14.71M	652.59%5.14M	0	0	0	5.14M	-60.91%682.97K	-94.06%98.53K	572.01%584.45K	0
Net common stock issuance	176.38%16M	747.61%5.79M	--0	--0	--0	--5.79M	-55.61%682.97K	-93.60%98.53K	--584.45K	--0
Proceeds from stock option exercised by employees	----	--0	----	----	----	----	--0	----	----	----
Net other financing activities	-98.77%-1.29M	---648.93K	--0	--0	--0	---648.93K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	186.18%14.71M	652.59%5.14M	--0	--0	--0	--5.14M	-60.91%682.97K	-94.06%98.53K	572.01%584.45K	--0
Net cash flow
Beginning cash position	-24.80%21.65M	-45.76%28.79M	-23.31%25.39M	-29.02%27.73M	-34.95%31M	-45.76%28.79M	-40.38%53.08M	-46.10%33.11M	-44.04%39.06M	-38.61%47.65M
Current changes in cash	398.21%10.77M	70.69%-7.13M	4.47%-3.75M	61.25%-2.33M	63.87%-3.22M	139.32%2.16M	32.31%-24.33M	53.96%-3.92M	26.25%-6.01M	-14.84%-8.9M
Effect of exchange rate changes	-105.01%-2.41K	-121.67%-8.4K	100.09%383	-105.89%-3.44K	-117.08%-53.5K	-32.22%48.16K	1,671.06%38.76K	-342.78%-403.97K	125.51%58.42K	619.10%313.25K
End cash Position	4.57%32.41M	-24.80%21.65M	-24.80%21.65M	-23.31%25.39M	-29.02%27.73M	-34.95%31M	-45.76%28.79M	-45.76%28.79M	-46.10%33.11M	-44.04%39.06M
Free cash flow	-32.39%-3.94M	50.94%-12.27M	6.81%-3.75M	64.69%-2.33M	63.87%-3.22M	45.79%-2.98M	33.63%-25.01M	60.50%-4.02M	19.93%-6.59M	-14.84%-8.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall